AZD 0328

Known as: AZD-0328, AZD0328 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2013
012320092013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Apatinib is a new oral antiangiogenic molecule that inhibits vascular endothelial growth factor receptor-2. The present study… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 3
Is this relevant?
2012
2012
Neuronal nicotinic acetylcholine receptor (nAChR) agonists active at the alpha-7 (α-7) receptor subtype are potential… (More)
Is this relevant?
2011
2011
BACKGROUND Nicotine improves cognition in humans and animal models of neuropsychiatric disorders. Here, we sought to establish… (More)
Is this relevant?
2011
2011
Αlpha-7 neuronal nicotinic receptors (NNRs) are considered targets for cognitive enhancement in schizophrenia and Alzheimer's… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
1. AZD0328 was pharmacologically characterized as a α7 neuronal nicotinic receptor agonist intended for treatment of Alzheimer's… (More)
Is this relevant?
2009
2009
AZD0328, a novel spirofuropyridine neuronal nicotinic receptor partial agonist, was used to investigate the role of alpha7… (More)
Is this relevant?